Susquehanna International Group
INBX

Susquehanna International Group’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Susquehanna International Group’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-31,100
Closed -$1.09M – 13635
2024
Q1 		$1.09M Sell
31,100
-30,600
-50% -$1.12M ﹤0.01% 6692
2023
Q4 		$2.34M Buy
+61,700
New +$1.32M ﹤0.01% 5033
2023
Q3 		– Sell
-15,800
Closed -$410K – 13528
2023
Q2 		$410K Sell
15,800
-42,800
-73% -$1,000K ﹤0.01% 8781
2023
Q1 		$1.11M Buy
58,600
+39,700
+210% +$923K ﹤0.01% 6543
2022
Q4 		$466K Sell
18,900
-1,500
-7% -$44.1K ﹤0.01% 8056
2022
Q3 		$366K Buy
+20,400
New +$368K ﹤0.01% 9305
2022
Q2 		– Sell
-13,200
Closed -$294K – 14664
2022
Q1 		$294K Buy
+13,200
New +$337K ﹤0.01% 10328

Other funds holding INBX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Susquehanna International Group's INBX Position: Q2 2024 in Review

Susquehanna International Group sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 63,710 shares — an estimated $2.23M sold.

Susquehanna International Group first reported a position in INBX in Q4 2021 and held it in 10 quarters. The position peaked at $4.04M in Q4 2023. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

  • Susquehanna International Group reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Susquehanna International Group sold 63,710 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $2.23M.
  • Susquehanna International Group first reported a position in Inhibrx, Inc. Common Stock in Q4 2021 and held it in 10 quarters.
  • Susquehanna International Group's Inhibrx, Inc. Common Stock position peaked at $4.04M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on Susquehanna International Group's 13F filing for Q2 2024, filed 15 Aug 2024.